Practice Therapeutics Pregabalin and gabapentin for pain BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1315 (Published 28 April 2020) Cite this as: BMJ 2020;369:m1315 Article Related content Metrics Responses Peer review Data supplement Web extra Files in this Data Supplement: Data Supplement - Infographic: Gabapentinoids for pain relief Related articles News UK government to reclassify pregabalin and gabapentin after rise in deaths Published: 25 September 2017; BMJ 358 doi:10.1136/bmj.j4441 Editorial Antidepressants for musculoskeletal pain Published: 20 January 2021; BMJ 372 doi:10.1136/bmj.n80 See more Two-drug antiretroviral regimens for HIV BMJ September 01, 2023, 382 e071079; DOI: https://doi.org/10.1136/bmj-2022-071079 Continuous glucose monitoring BMJ March 03, 2023, 380 e072420; DOI: https://doi.org/10.1136/bmj-2022-072420 Treatments for poorly controlled asthma BMJ October 04, 2021, 375 n2355; DOI: https://doi.org/10.1136/bmj.n2355 Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain BMJ January 29, 2021, 372 n104; DOI: https://doi.org/10.1136/bmj.n104 Warfarin in patients with mechanical heart valves BMJ October 15, 2020, 371 m3956; DOI: https://doi.org/10.1136/bmj.m3956 Cited by... Restoring invisible and abandoned trials of gabapentin for neuropathic pain: a clinical and methodological investigationAbstract Fulltext PDF Antidepressants for musculoskeletal painAbstract Fulltext PDF Drugs for chronic painAbstract Fulltext PDF
